In rheumatoid arthritis, IFN-γ and, in subsets, IFN-I contribute to synovial myeloid activation and GAS/ISRE-driven programs; downstream JAK inhibition partially mitigates these effects even when IFN is not the sole driver [86]. The gene discussed is IFNG; the disease is rheumatoid arthritis.